Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Devani K, Charilaou P, Radadiya D, Brahmbhatt B, Young M, Reddy C
Our findings reveal that exendin-4 and liraglutide significantly reduce hepatic cholesterol accumulation and suppress SREBP-2 expression, a crucial regulator of cholesterol metabolism, via activation of the SIRT6-AMPK pathway in PA-treated HepG2 cells
For example, a trial could be designed to enroll all high-risk ESCC patients identified preoperatively by biomarkers (e.g., PNI 900), who are then randomized into different intervention baskets, such as: (A) standard perioperative care
Currently, an ongoing clinical trial is evaluating the effects of simvastatin in patients with uterine fibroids (IRB Number: IRB00149869)
US$ 22.51
US$ 24.91
US$ 21.31
US$ 29.95
US$ 20.17
US$ 24.74
US$ 20.43
